 BERKELEY HEIGHTS, N.J., Nov. 05, 2020 GLOBE NEWSWIRE -- Cyclacel Pharmaceuticals, Inc. Nasdaq: CYCC Nasdaq: CYCCP Cyclacel or the Company, a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce third quarter 2020 financial results on Wednesday, November 11, 2020. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time on the same day. 